Sign in

CIK 0001674930 · Accelerated filer

Fulgent Genetics, Inc.

Sign in to watch
Ticker
FLGT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812621304
Phone
626-350-0537
Business address
4399 SANTA ANITA AVE, EL MONTE, CA, 91731
Former names
Fulgent Diagnostics, Inc.
  1. 4 Open-market sale President and COO sold 1,135 shares at $20.29 ($23,030)
  2. 144 Insider Sale of Securities
  3. 4 Open-market sale President and COO sold 1,873 shares at an average $20.54 ($38,468)
  4. 4 Shares withheld for taxes CFO and Treasurer gave up 1,837 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Executive Officer gave up 5,060 shares (to pay taxes)
  6. 4 Open-market sale Chief Scientific Officer sold 1,039 shares at an average $20.54 ($21,339)
  7. 4 Grant or award Director acquired 8,982 shares (grant or award)
  8. 4 Grant or award Director acquired 4,491 shares (grant or award)
  9. 4 Grant or award Director acquired 8,982 shares (grant or award)
  10. 8-K Event Shareholder vote results
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 1,339 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Scientific Officer gave up 79 shares (to pay taxes)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations · Regulation FD disclosure
  17. 4 Shares withheld for taxes President and COO gave up 4,353 shares (to pay taxes)
  18. 4 Shares withheld for taxes CFO and Treasurer gave up 2,743 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,157 shares (to pay taxes)
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 7 of 34 · 670 filings